Biotest GmbH & Co. KGaA Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-70.7	26.4	127	-31.7	-63.4
Depreciation & Amortization	38.8	40.5	35.8	35.8	31.1
Other Amortization	0.2	0.1	0.1	-	-
Loss (Gain) From Sale of Assets	-	-0.1	-23.1	-	-
Loss (Gain) on Equity Investments	-	14	-2.4	0.7	-1.3
Provision & Write-off of Bad Debts	4	-7.9	-	-	-
Other Operating Activities	11.3	-11.9	28.4	-0.1	45.9
Change in Inventory	-118.9	-11.4	-213.4	-76.1	23.8
Change in Accounts Payable	-9.5	7	45.3	24.8	-
Change in Other Net Operating Assets	-0.1	4.2	-0.4	6.1	-2.3
Operating Cash Flow	-144.9	60.9	-2.7	-40.5	33.8
Capital Expenditures	-11.6	-28.7	-33.4	-29.3	-18.2
Sale of Property, Plant & Equipment	0.5	0.2	1	-	0.3
Divestitures	-	-	35	-	-
Investment in Securities	1.3	1.7	-2.4	-7.8	-5.5
Other Investing Activities	1.2	1.1	1.1	0.1	-
Investing Cash Flow	-8.6	-25.7	1.3	-37	-23.4
Long-Term Debt Issued	149.7	197.4	10.1	100	25.1
Long-Term Debt Repaid	-6.3	-230.2	-19	-5.8	-5.3
Net Debt Issued (Repaid)	143.4	-32.8	-8.9	94.2	19.8
Common Dividends Paid	-0.8	-1.6	-	-0.8	-0.8
Other Financing Activities	-7.2	-1	2.1	-3.8	3.6
Financing Cash Flow	135.4	-35.4	-6.8	89.6	22.6
Foreign Exchange Rate Adjustments	0.1	-0.1	0.1	-	-
Miscellaneous Cash Flow Adjustments	-	-	-0.4	0.1	0.1
Net Cash Flow	-18	-0.3	-8.5	12.2	33.1
Free Cash Flow	-156.5	32.2	-36.1	-69.8	15.6
Free Cash Flow Margin	-24.12%	4.43%	-5.27%	-13.53%	3.03%
Free Cash Flow Per Share	-3.96	0.81	-0.91	-1.76	0.39
Cash Interest Paid	18.1	20.3	24.2	13.1	12.8
Cash Income Tax Paid	1.5	8.7	11.7	2	0.9
Levered Free Cash Flow	-106.11	-17.49	-68.74	-71.69	28.64
Unlevered Free Cash Flow	-84.61	1.45	-45.86	-60.13	36.39
Change in Working Capital	-128.5	-0.2	-168.5	-45.2	21.5